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Abstract
OBJECTIVES: Patients diagnosed with axillary hyperhidrosis can face psychosocial issues that can ultimately hinder their quality of life
both privately and socially. The routine treatment for axillary hyperhidrosis is T3–T4 sympathectomy, but compensatory sweating is a
serious side effect that is commonly seen with this approach. This study was designed to evaluate whether a T3 sympathectomy was ef-
fective for the treatment of axillary hyperhidrosis and whether this treatment led to less compensatory sweating than T3–T4 sympathec-
tomies among our 60-patient population.
METHODS: One hundred and twenty endoscopic thoracic sympathectomies were performed on 60 patients who had axillary hyper-
hidrosis. The sympathectomies were accomplished by means of a single-lumen endotracheal tube and a single port. The axillary hyper-
hidrosis patients were randomly divided into two groups with 17 patients in Group 1 undergoing T3–T4 sympathectomies and 43 in
Group 2 undergoing only T3 sympathectomies. We analysed the data associated with the resolution of axillary hyperhidrosis, the
degree of patient satisfaction with the surgical outcome and the quality of life in parallel with compensatory sweating after the proced-
ure as reported by the patient and confirmed by the examiner. Moreover, the results were compared statistically.
RESULTS: No statistically significant difference was observed between the groups based on age (P = 0.56), gender (P = 0.81), duration of
the surgery (P = 0.35) or postoperative satisfaction levels (P = 0.45). However, the incidence and degree of compensatory sweating were
lower in the T3 group than the T3–T4 group at the 1-year follow-up (P = 0.008).
CONCLUSIONS: T3 sympathectomy was as effective as T3–T4 sympathectomy for the treatment of axillary hyperhidrosis based on the
patients’ reported postoperative satisfaction, and the T3 group demonstrated lower compensatory sweating at the 1-year follow-up.
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INTRODUCTION
Axillary hyperhidrosis is an important disease that affects 1.4%
of the population and can cause serious emotional and work-
related problems [1]. Various medical treatment options for the
treatment of axillary hyperhidrosis are available, including
topical and systemic therapies, iontophoresis, regional nerve
block and botulinum toxin injections. Medical management is
often frustrating, and the response to treatment is generally tran-
sient [1, 2]. Thoracoscopic sympathetic surgery where the T3 and
T4 sympathetic ganglia are resected through one or two ports is
currently the most effective treatment for axillary hyperhidrosis.
Patients are usually satisfied with the surgical outcome during
the early postoperative period, but often suffer the recurrence
of symptoms or compensatory sweating (CS) during the late
postoperative period. In fact, CS is the factor that has the most
influence on the postoperative quality of life of the patients and
is considered a marker of the quality of the sympathectomy [3].
Researchers have reported that cutting at lower levels leads to
less CS in axillary hyperhidrosis [2].
Endoscopic thoracic sympathectomy (ETS) is usually used to
treat palmar hyperhidrosis in our clinic, but not axillary hyper-
hidrosis or facial flushing. Palmar hyperhidrosis and axillary
hyperhidrosis are frequently seen together, and we observed
that axillary hyperhidrosis resolved in patients with palmar
hyperhidrosis who were treated with a T3 sympathectomy;
moreover, these patients had less CS during the follow-up
period. We did not find any studies in the literature on the
results from a T3 sympathectomy for the treatment of axillary
hyperhidrosis. We, therefore, compared the axillary hyperhidro-
sis treatment results and any associated CS following treatment
with T3 sympathectomy vs that of treatment with T3–T4 sym-
pathectomy. More specifically, we compared the results, degree
of satisfaction and CS of patients who underwent thoracic
sympathectomy at only the T3 level vs the T3 and T4 levels for
axillary hyperhidrosis.
© The Author 2013. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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MATERIALS AND METHODS
This two-cohort, observational, single-centre study included
patients undergoing bilateral ETS for the treatment of axillary
hyperhidrosis by the Pamukkale University Faculty of Medicine
in the Department of Thoracic Surgery. Sixty patients who had
axillary hyperhidrosis and may or may not have had palmar
hyperhidrosis underwent ETS between May 2008 and December
2010; the patients were monitored for 1 year and only the
results of the treatment for axillary hyperhidrosis were evaluated.
The exclusion criteria were as follows: history of previous thor-
acic surgery or associated diseases that could increase surgical
risks (e.g. cardiac diseases, pulmonary infections, neoplasias or
diseases of the pleura or lungs), a body mass index >25 and iso-
lated Grade 1 axillary hyperhidrosis [4]. All participating patients
stated that their symptoms had become more evident during
puberty and increased when they were under stress. The pre-
operative sweating levels of the patients were rated using 4
grades according to the Hyperhidrosis Disorder Severity Scale
(HDSS) [5] (Table 1).
The sympathetic chain was treated with electrocautery at the
R3 level for the T3 sympathectomy and the R3–R4 level for the
T3–T4 sympathectomy. Axillary hyperhidrosis patients were ran-
domly divided into two groups using a randomization table with
the intent of performing two times more T3 procedures than
T3–T4 procedures; i.e. 17 patients were assigned to Group 1 and
underwent T3–T4 sympathectomy, whereas 43 patients were
assigned to Group 2 and underwent T3 sympathectomy. Both
surgeries focused on the rami communicanti. All patients sched-
uled for sympathectomy were informed that CS may develop
after surgery. Patients in both groups were outpatients with axil-
lary hyperhidrosis that was rated Grade 2 or more according to
the HDSS. In addition, all patients with Grade 1 axillary hyper-
hidrosis accompanied by palmar hyperhidrosis were included in
the T3 group (i.e. Group 2).
All sympathectomies were done by the same surgical team
using a standardized technique. All patients were monitored
and asked to complete a postoperative questionnaire survey
one year after surgery. A chest X-ray was performed following
the operation in order to assess lung expansion. We analysed
the data related to the resolution of the symptoms associated
with axillary hyperhidrosis according to the HDSS [5], CS (i.e. oc-
currence and quantification), degree of patient satisfaction with
the surgical outcome and the quality of life associated with CS in
the early postoperative period (i.e. first day after the procedure)
and in the late postoperative period (i.e. 12 months after
the procedure) as reported by the patient and confirmed by the
examiner. Each patient’s quality of life was assessed based on the
patient’s statements regarding the degree of CS that they experi-
enced over time.
Patient satisfaction and quality-of-life measures included both
the treatment and side effects, particularly CS, and were subject-
ively graded by the participants for scores between 1 and 4 with
1 referring to dissatisfied, 2 referring to fair, 3 referring to very
good and 4 referring to excellent for axillary hyperhidrosis.
Operative technique
All patients underwent general anaesthesia and orotracheal in-
tubation with a simple cannula during surgery. All patients were
positioned in a semi-sitting position with their arms raised
during the operation. Essentially, to perform the sympathectomy,
we used a rigid thoracoscope (0° telescope, Karl Storz, Germany)
via a 10-mm trocar with an obturator and a cannula. A separate
channel was available inside the thoracoscope for the use of the
forceps or the aspirator. A 1-cm incision was made in each
hemithorax at the third or fourth intercostal space on the mid-
axillary line, and then a 10-mm diameter thoracoscope was
inserted into the thoracic cavity to identify the T3 and T4 sympa-
thetic ganglion via inspection. In order to identify anatomical
landmarks, pneumothorax was induced in all patients via tem-
porary apnea [6]. An electrocautery hook was inserted to isolate
and cut the sympathetic chain at the T3 level or the T3 and T4
levels in Group 2 or Group 1, respectively. After the sympathec-
tomy, the lung was re-expanded under direct viewing, and the
air was simultaneously aspirated from the pleural space using a
small catheter (i.e. 16 Fr). The same procedure was carried out
on the contralateral chain. The catheter was removed, and the
incisions were closed using an absorbable suture. The use of a
chest drain was not routine.
Statistical analysis
The data were stored in a database and exported to the Statistical
Package for Social Sciences, version 14.0 (SPSS Inc., Chicago, IL,
USA) for analysis. For categorical variables, the χ2 test was used.
The associations between age, degree of satisfaction and ganglion
resection level (i.e. T3–T4 or T3) were investigated using the
Kruskal–Wallis one-way analysis of variance (i.e. a non-parametric
test), and a P-value that was <0.05 was accepted as significant.
Significance for all tests was defined at 5%.
RESULTS
Of the 60 patients, 29 were females and 31 were males. The
mean age was 25 ± 10.2 years, with a range of 14–42 years.
Table 2 presents the distribution of the axillary hyperhidrosis
cases according to HDSS and the patients’ demographic charac-
teristics according to the HDSS results. Only 2 had axillary hyper-
hidrosis without palmar hyperhidrosis.
No statistically significant differences were observed between
Group 1 and Group 2 for age (P = 0.56), gender (P = 0.81), dur-
ation of surgery (P = 0.35), and postoperative satisfaction level
(P = 0.45), but the incidence and degree of CS were significantly
lower in Group 2 than Group 1 at the 1-year follow-up
(P = 0.008) (Table 3).
Table 1: Preoperative sweating levels according to the
hyperhidrosis disorder severity scoring (HDSS)
HDSS
Grade 1 Minimal No visible sweating
Grade 2 Mild Visible sweating
Grade 3 Moderate Visible and embarrassing sweating
Grade 4 Maximal At least two clothing changes caused
by sweating of the same intensity as
the previous axillary hyperhidrosis
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The symptoms disappeared completely after the operation in
all patients, and the therapeutic success rate was considered to
be 100%. No recurrence of axillary hyperhidrosis was reported at
the 12-month follow-up in either group. All patients from both
groups rated their postoperative satisfaction level for relief from
axillary hyperhidrosis at Grades 3 and 4.
The incidence of CS was lower in Group 2 than Group 1 at
the 12 month follow-up. More specifically, all (i.e. 100%) Group
1 patients and 34 (i.e. 79%) Group 2 patients experienced CS.
Moreover, a statistically significant difference was observed
between the postoperative CS grades of the two groups
(P = 0.008). CS affected more than two regions in 5 patients
within Group 1 (i.e. 29%) but only 1 patient within Group 2 (i.e.
2%). The most common site of CS was the back (i.e. for 27
patients in total), followed by the abdominal region (i.e. for 16
patients in total). The incidence and severity of CS for both
Groups 1 and 2 are presented in Table 4.
Most patients in both groups were discharged 8–24 h after the
surgery. However, 1 patient from Group 1 and 1 from Group 2
experienced a postoperative partial pneumothorax, and 1
patient from Group 1 experienced a haemothorax that did not
require a thoracotomy case; these patients were discharged 72 h
after the surgery because they required the placement of a chest
tube. No postoperative mortality occurred in either group. Pain
was transiently experienced by the patients only on the first day
and was ameliorated by analgesics in the early postoperative
stage for patients in both groups.
DISCUSSION
Axillary hyperhidrosis is a disease characterized by the excessive
production of sweat. This condition commonly affects youth and
can create significant psychological and social issues for the
patient. Hyperhidrosis is defined as a complex dysfunction of the
autonomic nervous system that includes excessive sympathetic
activity and compensatory parasympathetic activity. The typical
treatment approach focuses on decreasing sympathetic activity
and promoting parasympathetic activity via a sympathectomy
[7–10]. First-line non-surgical therapies involving topical antiper-
spirants, such as aluminium chloride, are often short-acting,
require frequent reapplication, are ineffective in reducing sweat
production, and can cause irritant dermatitis [11]. Seven patients
(i.e. 12%) in the present study population had been treated for
3 months with topical agents, through which a temporary remis-
sion was obtained. Botox injections were recommended when
the symptoms reoccurred, and the patients who did not want to
pursue this procedure presented at our clinic. The other patients
had not received any other treatment for hyperhidrosis.
Although injections of botulinum toxin type A are a safe, rapid,
relatively durable and effective way to treat symptomatic axillary
hyperhidrosis, the subjects in our patient group rejected this
treatment approach and preferred to treat hyperhidrosis per-
manently through surgery.
Sweating can occur for thermoregulatory purposes or be asso-
ciated with an emotional response. Most sweat glands are of the
eccrine type and are usually seen in the axillae, palms and
plantar regions. All these glands become active with puberty.
This may explain why hyperhidrosis is rarely seen at an early age
and generally becomes evident in the second and third decades
of life, which is true for our patient population [11, 12] ETS is an
effective treatment for axillary hyperhidrosis, i.e. with a success
rate of 89%, and a well-established procedure [6, 10, 13]. The op-
erative scars are very small compared with open thoracotomy,
which is very important, particularly to young people [3, 10]. We
used ETS to accomplish the sympathectomy on account of the
aforementioned advantages. Our results were similar to those
reported from other studies.
The best ganglia level for sympathectomy and the optimal
technique used to interrupt the sympathetic chain remain the
subject of debate. Most authors agree on the use of T3–T4 sym-
pathectomy to treat axillary hyperhidrosis [7–9]. Indeed, the
results from T3–T4 sympathectomies for the treatment of axillary
hyperhidrosis and the subsequent CS have been reported in
Table 3: Demographic characteristics, operation durations, patient satisfaction levels, and compensatory sweating and
complication incidences of the patients in Group 1 and Group 2
Group 1 Group 2 P-values
Mean age (years) 25.52 ± 8.63 (16–42) 24.09 ± 8.30 (14–35) 0.56
F/M ratio 8/9 21/22 0.81
Operation time (min) 25 ± 3.3 (18–30) 16 ± 1.5 (13–22) 0.35
Postoperative satisfaction level n = 11 (excellent) (65%) n = 6 (very good) (35%) n = 38 (excellent) (88%) n = 5 (very good) (12%) 0.45
Compensatory sweating n = 17 (100%) n = 34 (79%) 0.008
Complication One haemothorax (28-Fr tube), one
pneumothorax (small calibre chest tube)
One pneumothorax (small calibre chest tube),
one subcutaneous emphysema
Table 2: HDSS and demographic distribution of the
patients for axillary hyperhidrosis
HDSS+1 HDSS+2 HDSS+3 HDSS+4
Number of
patient’s (n)
9 12 16 23
Group 1 – 3 6 8
Group 2 9 9 10 15
Mean age (years) 24.00 ± 8.2 20.33 ± 7.8 23.75 ± 5.9 25.00 ± 6.8
F/M ratio 5/4 5/7 8/8 10/13
General F/M ratio 29/31
General mean
age (years)
25 ± 10.2 (14–42)
O
R
IG
IN
A
L
A
R
TI
C
LE
G. Yuncu et al. / Interactive CardioVascular and Thoracic Surgery 265
D
ow
nloaded from
 https://academ
ic.oup.com
/icvts/article/17/2/263/787709 by Pam
ukkale U
niversity user on 08 Septem
ber 2020
many studies [8, 9]. Munia et al. observed that both T3–T4 and
T4 sympathectomies were effective in all cases for the treatment
of axillary hyperhidrosis at both 1 month and 6 months after the
procedure, but CS was seen less commonly following the T4
sympathectomy [10]. Munia and Decampos also reported that
cutting fewer levels leads to less reflex sweating in patients with
axillary hyperhidrosis, but did not evaluate the effect of the T3
sympathectomy alone. Our aim in this study was to compare the
effects of the T3 sympathectomy alone to that of the T3–T4 sym-
pathectomy as used in the treatment of axillary hyperhidrosis
patients regarding the treatment effectiveness and degree of
postoperative CS. Moreover, since axillary and palmar hyperhi-
drosis are frequently seen together, another aim of this study
was to determine whether both areas could be treated with a
single-level incision. However, our study was limited due to the
low number of patients who participated in the investigation,
particularly in the T3–T4 group. However, the effects of the T3–
T4 sympathectomy on axillary hyperhidrosis and CS are well
known from previous studies. Therefore, our focus was not to es-
tablish the effects of the T3–T4 sympathectomy; rather, we
intended to investigate the effectiveness of the T3 sympathec-
tomy in comparison with that of the T3–T4 sympathectomy for
the treatment of axillary hyperhidrosis. Furthermore, we demon-
strated that a lower CS incidence was observed when the lower
incision level was used.
The complication rate associated with thoracoscopic sympath-
ectomy for the treatment of palmar and axillary hyperhidrosis
can reach 10% [11, 14]. We encountered early complications in 2
patients in Group 2 and 2 in Group 1. Our total surgical compli-
cation rate was 6.6%, which is lower than that of other studies
[11, 14]. The most troublesome postoperative side effect reported
by patients is CS; yet, the nature of CS after sympathectomy is
unknown [12–14]. CS has been reported as less common in
patients who underwent denervation of 1 or 2 ganglia when
compared with those undergoing denervation of three ganglia
[3, 12, 15]. We, therefore, used the T3 sympathectomy to treat ax-
illary hyperhidrosis in patients in Group 2, and we found that CS
was less common according to the HDSS in Group 2 than Group
1. In fact, 21% (n = 9) of Group 2 reported no CS, while no one
in Group 1 patients reported no CS. Severe CS occurred on the
back and the abdomen in our series of patients, which is similar
to the findings of other studies [3, 10]. CS in more than two
regions was present in 1 patient in Group 2 and given a grade of
3, whereas CS in more than two regions was present in 5
patients in Group 1 and rated as a grade of 4. We found that ax-
illary sweating had resolved in the postoperative period in all
patients in Group 2 and Group 1.
Another limitation of our study is the fact that the satisfaction
expressed by the patients after surgery was subjective.
Nevertheless, even if we had incorporated an objective sweating
test, these results would have only reflected the findings at one
given time under a given emotional state at that time.
Unfortunately, no methods have been developed to measure
hyperhidrosis over the course of an entire day. However, the
main factors contributing to patient satisfaction in the treatment
of axillary hyperhidrosis are the resolution of current symptoms
with no CS [10, 13]. Axillary hyperhidrosis symptoms resolved
after ETS in both groups in our study, and no patients reported
recurring symptoms at the end of a year. The lowest satisfaction
score was 3 (i.e. very good), and these patients reported some
CS symptoms. We observed that resolved axillary hyperhidrosis
symptoms with no recurrence for an extended time after surgery
satisfied the patients and increased their quality of life even
when CS was present.
In conclusion, we found that T3 sympathectomy was as effect-
ive as T3–T4 sympathectomy for the treatment of axillary hyper-
hidrosis in terms of satisfaction level and resulted in a lower CS
rate in this study. CS, usually considered a serious side effect of
surgical treatment of hyperhidrosis, is cosmetically bothersome
and unwanted; therefore, we conclude that T3 sympathectomy is
preferable to T3–T4 sympathectomy for the treatment of axillary
hyperhidrosis, and another aim of this study was to determine
whether both areas (palmar and axillary) could be treated with
T3 sympathectomy.
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